LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)

Sponsor
Spanish Lung Cancer Group (Other)
Overall Status
Completed
CT.gov ID
NCT04344002
Collaborator
(none)
886
75
17.5
11.8
0.7

Study Details

Study Description

Brief Summary

This is a multi-centre study on lung cancer patients which experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers and COVID-19 infection. Firstly, investigators will be registered in an online secure registry. After that, a protocol will be developed in order to collect clinical data for the research. It will also include I on the care organization or the perception of the patient and their family members.

The final stage will consist on retrospective data collection from patients. So, it is a retrospective study data collection, preceded by prospective data registry.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    886 participants
    Observational Model:
    Cohort
    Time Perspective:
    Other
    Official Title:
    Observational Retrospective Register of Spanish Lung and Melanoma Cancer Patients With COVID19 Disease
    Actual Study Start Date :
    Apr 21, 2020
    Actual Primary Completion Date :
    Oct 6, 2021
    Actual Study Completion Date :
    Oct 6, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    lung cancer+COVID-19

    lung cancer patients diagnosed with COVID-19

    Outcome Measures

    Primary Outcome Measures

    1. Clinical data of lung cancer patients with COVID-19 diagnoses [From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years]

      Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as clinical data.

    2. Diagnosis data [From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years]

      Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as data about diagnosis

    3. Treatments received [From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years]

      Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as treatments received

    4. Prognostic factors [From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years]

      Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as prognostic factors.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients diagnosed with lung cancer

    • Patients who have contracted COVID-19 infection

    Exclusion Criteria:
    • Patients diagnosed with lung cancer but no confirmation of COVID-19 infection.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Complejo Hospitalario Universitario de Ferrol Ferrol A Coruña Spain
    2 H. Clínica Benidorm Benidorm Alicante Spain 03501
    3 Hospital de Elche Elche Alicante Spain 03202
    4 Hospital General Universitario de Elda Elda Alicante Spain 03600
    5 Hospital de Torrevieja Torrevieja Alicante Spain 03186
    6 Hospital Universitari Germans Trias i Pujol Badalona Barcelona Spain 08916
    7 Cetir Centre Mèdic Esplugues De Llobregat Barcelona Spain
    8 Hospital General de Granollers Granollers Barcelona Spain
    9 Hospital Universitario de Galdakao Galdakao Bizkaia Spain
    10 Complejo Hospitalario de la Coruña La Coruña Coruña Spain 15006
    11 H. Insular de Gran Canarias Las Palmas De Gran Canaria Gran Canarias Spain 35016
    12 Hospital San Pedro Logroño La Rioja Spain
    13 Hospital Universitario Fundación Alcorcón Alcorcón Madrid Spain 28922
    14 Hospital Severo Ochoa Leganés Madrid Spain 28911
    15 Hospital Universitario de Móstoles Móstoles Madrid Spain
    16 Hospital de Manacor Manacor Mallorca Spain
    17 Hospital Costa del Sol Marbella Málaga Spain 29603
    18 Clínica Universidad de Navarra Pamplona Navarra Spain 31008
    19 Clínica Universitaria de Navarra Pamplona Navarra Spain 31008
    20 Complejo Hospitalario de Navarra Pamplona Navarra Spain
    21 Hospital Instituto Onkologikoa San Sebastián País Vasco Spain
    22 Hospital Sant Joan de Reus Reus Tarragona Spain 43204
    23 Hospital Verge de la Cinta Tortosa Tarragona Spain
    24 H. Universitario de Canarias La Laguna Tenerife Spain 38320
    25 Hospital Universitario de La Ribera Alzira Valencia Spain
    26 Hospital de Manises Manises Valencia Spain
    27 Hospital de Cruces Baracaldo Vizcaya Spain 48903
    28 Hospital de Basurto Bilbao Vizcaya Spain 48013
    29 H. Gen. Universitario Alicante Alicante Spain
    30 H. Universitario Quirón Dexeus Barcelona Spain 08036
    31 Hospital Clínic de Barcelona Barcelona Spain 08036
    32 H. Duran i Reynals-ICO Barcelona Spain 08907
    33 Hospital de la Santa Creu i Sant Pau Barcelona Spain
    34 Hospital del Mar Barcelona Spain
    35 Hospital La Mancha Centro Ciudad Real Spain
    36 Hospital Virgen de la Luz Cuenca Spain 16002
    37 Hospital Universitario de Puerto Real Cádiz Spain
    38 Hospital Dr. Josep Trueta Girona Spain 17007
    39 Hospital Universitario Virgen de las Nieves Granada Spain
    40 Hospital de Guadalajara Guadalajara Spain 19002
    41 Complejo Asistencial Universitario de León León Spain 24071
    42 Hospital San Millan Y San Pedro Logroño Spain
    43 Hospital Universitario Lucus Augusti Lugo Spain 27003
    44 MD Anderson Madrid Spain 28033
    45 H.U. Puerta de Hierro Madrid Spain 28035
    46 Fundación Jimenez Diaz Madrid Spain 28040
    47 Hospital Universitario Infanta Sofía Madrid Spain 28703
    48 Hospital 12 de Octubre Madrid Spain
    49 Hospital Clínico San Carlos Madrid Spain
    50 Hospital de Sanchinarro Madrid Spain
    51 Hospital General Universitario Gregorio Marañón Madrid Spain
    52 Hospital Universitario de Fuenlabrada Madrid Spain
    53 Hospital Universitario del Henares Madrid Spain
    54 Hospital Universitario Infanta Leonor Madrid Spain
    55 Hospital General Universitario Morales Meseguer Murcia Spain
    56 Hospital Carlos Haya Málaga Spain
    57 Hospital Santa María Naí Ourense Spain
    58 Hospital Son Espases Palma de Mallorca Spain 07010
    59 H. Son Llàtzer Palma de Mallorca Spain 07198
    60 Hospital Clinico de Salamanca Salamanca Spain 37007
    61 Hospital General de Segovia Segovia Spain
    62 Hospital Virgen del Rocío Sevilla Spain 41013
    63 Hospital Sant Pau i Santa Tecla Tarragona Spain 43003
    64 Hospital universitario Nuestra Señora Candelaria Tenerife Spain
    65 H. General U. de Valencia Valencia Spain 46014
    66 Hospital Arnau de Vilanova Valencia Spain
    67 Hospital Clínico Universitario de Valencia Valencia Spain
    68 Hospital Dr. Peset Valencia Spain
    69 Hospital Politècnic i Universitari La Fe Valencia Spain
    70 Hospital Universitario Dr. Peset Valencia Spain
    71 Instituto Valenciano de Oncología Valencia Spain
    72 Hospital Clínico Universitario de Valladolid Valladolid Spain 47003
    73 H. Miguel Servet Zaragoza Spain 50009
    74 Hospital Ntra. Sra. Sónsoles Ávila Spain
    75 Hospital Universitario de Áraba Vitoria Áraba Spain 01009

    Sponsors and Collaborators

    • Spanish Lung Cancer Group

    Investigators

    • Study Chair: Mariano MD Provencio, MD, Hospital Puerta de Hierro de Majadahonda de Madrid
    • Study Chair: Cristina MD Avendaño Solá, MD, Hospital Puerta de Hierro de Majadahonda de Madrid
    • Study Chair: María MD González-Cao, MD, Hospital Universitario Dexeus de Barcelona.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Spanish Lung Cancer Group
    ClinicalTrials.gov Identifier:
    NCT04344002
    Other Study ID Numbers:
    • GECP 20/02_GRAVID
    First Posted:
    Apr 14, 2020
    Last Update Posted:
    Jun 27, 2022
    Last Verified:
    Jun 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Spanish Lung Cancer Group
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 27, 2022